Conventional wearable ultrasound sensors have been limited by low power output and poor structural stability, making them ...

Columbia researchers show for the first time that focused ultrasound can safely open the blood-brain barrier in children, enhancing delivery of chemotherapy to tumors.

Pulsenmore’s at-home ultrasound platform, Pulsenmore ES, has received de novo authorisation from the US Food and Drug Administration (FDA). Pulsenmore ES enables pregnant women to perform guided scans ...

Hisense Ghana's commitment as a global technology leader transcends the home and extends into the critical sphere of public ...

Conventional wearable ultrasound sensors have been limited by low power output and poor structural stability, making them unsuitable for high-resolution imaging or therapeutic applications.

The veterans advocate, nationally known for his “Men’s Health’ cover and ‘Dancing with the Stars’ appearance, uses the ...

Credit: Pulsenmore. Based on these scans, clinicians are able to assess fetal heartbeat, fetal movements, and amniotic fluid volume. The product is expected to launch in the US in early 2026. The Food ...

This authorization introduces to the United States a proven care model that connects expectant mothers and physicians through guided imaging and secure digital review- amid growing constraints on ...

Registration opens today with a significantly reduced rate for those in training and a tighter, more focused program ...

Pulsenmore Ltd., a pioneer in home ultrasound solutions, announced that the US Food and Drug Administration (FDA) has granted De Novo marketing authorization for the Pulsenmore ES, a home-use prenatal ...